Article

Epidermal growth factor receptor (EGFR) as a key regulator in type 2 diabetes: Drug discovery insights

2025-02-01

Abstract excerpt

Type 2 diabetes (T2D) is a complex metabolic disorder with incompletely understood molecular mechanisms. This study aimed to elucidate the T2D regulatory network and identify potential drug targets and candidates. We performed differential gene expression analysis on multiple T2D datasets, constructed protein-protein interaction networks, and conducted a meta-analysis to identify key hub genes. Functional enrichme...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4ee7f90a-e2ce-58ec-9562-076112d1ac34
DOI: 10.1016/j.humgen.2025.201390

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Epidermal growth factor receptor (EGFR) as a key regulator in type 2 diabetes: Drug discovery insightsDOI 10.1016/j.humgen.2025.201390Read

Elucidating the Type 2 Diabetes Regulatory Network: Identification of EGFR as a Key Hub and Novel Drug CandidatesSemantic proximity Read

Uncovering the gene regulatory network of type 2 diabetes through multi-omic data integrationSemantic proximity Read

Multi-omics regulatory networks reveal the key driver genes in the development of type 2 diabetesSemantic proximity Read

Bioinformatics and network biology approach to identifying type 2 diabetes genes and pathways that influence the progression of breast cancerSemantic proximity Read

Exploring the therapeutic potential of Rutin and Morin in Type 2 Diabetes: A transcriptomics and molecular dynamics simulation for proteinsSemantic proximity Read

Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug moleculesSemantic proximity Read

Integrative Gene Target Mapping, RNA Sequencing, In Silico Molecular Docking, ADMET Profiling and Molecular Dynamics Simulation Study of Marine Derived Molecules for Type 1 Diabetes MellitusSemantic proximity Read

Identification of key genes, biological functions, and pathways of empagliflozin by network pharmacology and its significance in the treatment of type 2 diabetes mellitusSemantic proximity Read

Transcriptome-Wide Identification of Hub Genes and Therapeutic Targets in Type 2 Diabetes Mellitus Through Integrated Bioinformatics and Molecular Docking-Based Drug RepurposingSemantic proximity Read

Bioinformatics Analysis of next generation sequencing data for Risk Prediction in Patients with Type 1 diabetes mellitusSemantic proximity Read

Single-Cell RNA Sequencing Analysis of Key Candidate Genes; Molecular Modeling and Docking-Based Therapeutic Molecules Exploration of Nature Derived Phytoconstituents for Type 2 Diabetes Mellitus.Semantic proximity Read

Material Basis and Mechanisms of Action of PuRenDan in the Treatment of Type 2 Diabetes Mellitus: An Integrated Network Pharmacology and Molecular Simulation StudySemantic proximity Read